Search PubMed⌕ Search

Biomedical subjects

W F Whitmore

Publications and source records attributed to W F Whitmore.

At least 325 records · Page 18Linked to original sources

Study of local and systemic effects of intravesical BCG.

Defects in cell-mediated immunity have been implicated as one of the underlying causes for the appearance and progression of neoplasms. One approach toward correcting these defects employs immune potentiators for the purpose of stimulating cell-mediated immunity. BCG is the immune potentiator which has been used most frequently in the experimental and clinical situation. A preliminary study directed toward ascertaining the local histologic changes and systemic serum response to BCG injection in the dog bladder was undertaken in anticipation of its possible application in the treatment of bladder neoplasm. Local response was predictable and was associated with low morbidity. The appearance of serum precipitin bands to culture filtrates of Mycobacteria tuberculosis strains strongly suggests systemic absorption and reaction to BCG administered intravesically.

Animals↗

Ureteral carcinoma in situ.

The incidence of ureteral carcinoma in situ at the time of cystectomy for bladder carcinoma is approximately 8.7 per cent. Followup records of 27 such patients as well as records of 6 patients with other ureteral abnormalities were reviewed. Clinically, no postoperative ureteral or upper urinary tract difficulty was noted in 29 of the 30 patients whose records were complete. The ureteral status of the 3 patients lost to followup remains uncertain. One patient had infiltrating ureteral carcinoma and he is well 8 years after cystectomy. Since ureteral carcinoma in situ at the time of cystectomy for bladder cancer has had little influence on the course of these patients, conservative treatment is probably indicated when the lesion is encountered.

Carcinoma in Situ↗

Radiation therapy and pelvic node dissection in the management of cancer of the prostate.

A technique involving a pelvic lymphadenectomy and a retropubic implantation of the prostate with iodine 125 encapsulated sources is under investigation at Memorial Hospital. This technique is simple and applicable to patients with localized cancer of the prostate, clinically stage B or C. It has increased the accuracy of staging, carries no mortality and has low morbidity. The results have been encouraging with substantial local tumor control and no late urinary or rectal disturbances in the 49 patients who have been followed from 6 to 30 months.

Aged↗